viral
infect
infanc
particularli
rhinoviru
rv
respiratori
syncyti
viru
rsv
import
risk
factor
wheez
episod
asthma
asthma
exacerb
rv
infect
import
risk
factor
develop
atop
asthma
like
mechan
reli
allerg
sensit
rsv
infect
import
risk
factor
develop
nonatop
asthma
like
differ
mechan
rv
neutrophil
dendrit
cell
respons
viral
infect
appear
import
contributor
h
respons
defin
atop
asthma
understand
associ
among
viral
infect
atopi
asthma
help
guid
appropri
treatment
strategi
viralinduc
exacerb
asthma
object
synthes
avail
data
relat
complex
associ
among
viral
infect
atopi
asthma
data
sourc
key
histor
articl
articl
highlight
recent
review
signific
recent
asthma
advanc
find
sever
birth
cohort
relat
asthma
viral
infect
review
addit
pubm
search
review
articl
origin
research
relat
associ
viral
infect
asthma
use
search
word
asthma
viral
infect
atopi
develop
asthma
rhinoviru
rv
respiratori
syncyti
viru
rsv
studi
select
articl
select
base
novelti
relev
topic
interest
role
asthma
viral
infect
possibl
mechan
explain
associ
result
larg
bodi
evid
demonstr
link
earli
viral
infect
especi
rv
rsv
asthma
incept
exacerb
rvinduc
wheez
import
risk
factor
asthma
atopi
present
much
evid
support
idea
sensit
risk
factor
earli
rvinduc
wheez
turn
risk
factor
asthma
rsv
hand
import
risk
factor
nonatop
asthma
sever
infect
confer
greater
risk
conclus
import
differ
develop
atop
nonatop
asthma
sever
propos
mechan
explain
associ
viral
infect
develop
asthma
asthma
exacerb
understand
complex
associ
import
develop
asthma
prevent
strategi
target
asthma
therapi
asthma
common
chronic
medic
condit
pediatr
popul
affect
children
adolesc
character
chronic
inflamm
airway
excess
mucou
product
bronchial
hyperreact
revers
airflow
obstruct
lead
recurr
episod
wheez
dyspnea
cough
review
discuss
strong
link
asthma
viral
infect
viral
infect
trigger
infant
wheez
episod
implic
incept
asthma
recogn
import
risk
factor
asthma
exacerb
fig
mani
children
wheez
first
year
life
studi
cite
children
wheez
school
age
children
develop
asthma
subset
children
develop
asthma
even
without
wheez
infant
almost
wheez
episod
first
year
life
occur
viral
infect
commonli
rhinoviru
rv
respiratori
syncyti
viru
rsv
enteroviru
bocaviru
parainfluenza
viru
coronaviru
metapneumoviru
influenza
viru
adenoviru
also
implic
bronchiol
common
condit
character
inflamm
small
bronchiol
surround
tissu
children
year
age
caus
viral
infect
lower
airway
bronchiol
affect
infant
first
year
life
infant
second
year
life
wheez
often
characterist
find
bronchiol
mandatori
symptom
includ
dri
cough
tachypnea
widespread
crackl
breath
difficulti
rsv
common
caus
bronchiol
first
year
life
usual
occur
winter
rsv
often
affect
infant
critic
time
lung
develop
consequ
may
affect
longterm
lung
develop
although
rsv
may
lead
sever
infect
infect
asymptomat
present
mild
ill
risk
factor
rsvinduc
wheez
includ
prematur
heart
lung
immun
system
abnorm
age
season
birth
month
age
winter
rsv
season
wherea
rsv
common
caus
infant
wheez
first
year
life
rv
often
detect
viru
wheez
older
infant
toddler
second
common
caus
bronchiol
infant
younger
month
rv
infect
present
yearround
peak
incid
late
autumn
earli
spring
rv
infect
nonenvelop
positivestrand
rna
virus
mani
distinct
genotyp
divid
differ
speci
rva
rvb
rvc
base
genet
properti
rvc
virus
grow
convent
cell
cultur
identif
delay
detect
continu
reli
polymeras
chain
reaction
rva
rvc
often
associ
wheez
ill
infant
rvb
understand
risk
factor
progress
wheez
infant
develop
asthma
import
target
asthma
prevent
strategi
offer
anticipatori
guidanc
initi
wheez
episod
although
mani
virus
associ
wheez
infant
data
suggest
greatest
associ
rv
rsv
recurr
wheez
develop
asthma
fig
risk
factor
differ
allerg
nonallerg
asthma
modifi
asthma
predict
index
api
mainli
base
atop
characterist
often
use
predict
risk
schoolag
asthma
birth
cohort
studi
predict
atop
asthma
nonatop
asthma
lukkarinen
et
al
consid
characterist
use
api
combin
viral
origin
infant
hospit
firsttim
wheez
found
rvinduc
wheez
alon
sensit
eczema
predict
atop
asthma
school
age
hand
parent
smoke
rsv
infect
first
wheez
wheez
year
age
found
risk
factor
nonatop
asthma
schoolag
differ
risk
factor
highlight
import
mechanist
differ
rvinduc
rsvinduc
diseas
rvinduc
wheez
import
risk
factor
atop
individu
fig
mani
studi
found
earli
rvinduc
wheez
import
asthma
risk
factor
studi
estim
children
wheez
rv
first
year
life
develop
asthma
childhood
origin
asthma
coast
studi
birth
cohort
studi
prospect
follow
children
least
atop
parent
infant
wheez
rv
alon
like
develop
asthma
wheez
rsv
alon
rsv
rv
mani
studi
found
link
atopi
rvinduc
wheez
risk
asthma
increas
markedli
infant
rvtrigger
wheez
also
evid
allergen
sensit
australian
birth
cohort
demonstr
risk
wheez
year
age
associ
infant
rv
wheez
children
evid
sensit
furthermor
coast
studi
greatest
risk
asthma
infant
rv
wheez
sensit
least
one
aeroallergen
although
unclear
whether
sensit
viral
infect
came
first
seem
like
allerg
sensit
risk
factor
rvinduc
wheez
coast
studi
earlylif
aeroallergen
sensit
preced
rv
infect
lead
author
hypothes
allerg
sensit
may
drive
viral
wheez
children
sensit
multipl
aeroallergen
earli
life
highest
risk
persist
wheez
sever
asthma
exacerb
requir
hospit
impair
lung
function
mani
pathway
rv
infect
allerg
inflamm
potenti
explain
increas
risk
asthma
occur
rv
wheez
atopi
briefli
review
mechan
section
other
challeng
find
specif
viral
infect
signific
hypothes
number
lower
respiratori
tract
infect
first
year
life
signific
risk
factor
specif
viral
origin
number
earli
viral
infect
lower
airway
certainli
import
factor
coast
studi
found
number
rv
wheez
episod
close
associ
asthma
risk
howev
studi
reflect
belief
rvinduc
wheez
signific
risk
factor
develop
asthma
like
frequent
infant
rvwheez
episod
confer
higher
risk
metaanalysi
examin
origin
articl
found
associ
rvinduc
wheez
develop
childhood
asthma
although
link
rsv
asthma
long
suspect
associ
less
clear
onethird
children
rsv
develop
recurr
wheez
episod
rsvinduc
bronchiol
birth
cohort
studi
associ
asthma
allerg
sensit
conflict
result
regard
import
rsv
infect
develop
asthma
sigur
et
al
first
conduct
prospect
studi
includ
control
match
age
birthdat
sex
resid
found
increas
rate
asthma
infant
hospit
rsv
infanc
fact
incept
asthma
figur
associ
among
respiratori
virus
atopi
wheez
asthma
discuss
text
respiratori
syncyti
viru
rsv
strongli
associ
develop
wheez
infant
sever
infect
without
preexist
atopi
less
clear
dash
line
associ
rsv
infect
develop
atopi
well
asthma
adolesc
rhinoviru
rv
hand
drive
develop
wheez
asthma
presenc
preexist
atopi
unclear
associ
factor
drive
atop
nonatop
asthma
dot
line
viral
infect
includ
rv
rsv
also
abl
exacerb
exist
asthma
follow
cohort
year
age
report
increas
asthma
allerg
sensit
clinic
allergi
decreas
pulmonari
function
spirometri
rsv
group
tucson
respiratori
studi
nonselect
birth
cohort
studi
link
rsvinduc
bronchiol
asthma
year
studi
rsvinduc
wheez
risk
factor
recurr
wheez
risk
wheez
decreas
insignific
year
age
conflict
result
studi
sigur
et
al
finnish
studi
found
associ
rsv
selfreport
asthma
children
year
age
anoth
studi
found
infant
born
month
rsv
season
highest
risk
asthma
year
age
contrari
studi
coast
studi
australian
birth
cohort
highrisk
birth
cohort
identifi
associ
rsv
infant
develop
asthma
school
age
ambigu
result
among
studi
like
attribut
differ
popul
among
studi
mechan
differ
rv
rsv
caus
virusinduc
diseas
notabl
sensit
seem
risk
factor
infant
develop
rsvinduc
wheez
import
risk
factor
infant
rvtrigger
wheez
henc
rsv
less
signific
atop
popul
present
coast
studi
australian
studi
group
sever
rsv
infect
like
signific
risk
factor
develop
asthma
rsvinduc
wheez
risk
factor
like
attribut
differ
diseas
mechan
involv
antivir
respons
includ
enhanc
h
respons
genet
polymorph
briefli
discuss
mechan
section
review
parainfluenza
virus
also
implic
develop
asthma
studi
sweden
found
infect
rsv
influenza
parainfluenza
children
younger
month
lead
develop
h
cytokin
profil
despit
increas
bodi
evid
show
pivot
link
rvand
rsvinduc
wheez
episod
develop
asthma
remain
unclear
whether
infect
rv
andor
rsv
infanc
contribut
develop
asthma
simpli
marker
asthma
suscept
mani
dynam
come
togeth
produc
asthma
includ
host
environment
factor
children
sever
virusinduct
bronchiol
born
increas
bronchial
respons
compar
children
without
bronchiol
patient
asthma
alter
epitheli
immun
respons
rv
mani
posit
infant
rvwheez
episod
occur
infant
predispos
develop
asthma
host
factor
contribut
sever
viral
infect
predispos
patient
atopi
respond
viral
wheez
enhanc
airway
damag
may
actual
signific
risk
factor
develop
asthma
like
complex
interplay
among
viral
infect
sensit
environment
exposur
suscept
host
promot
asthma
viral
infect
often
associ
asthma
exacerb
contribut
acut
asthma
exacerb
serv
main
trigger
asthma
schoolag
children
adult
viral
infect
particularli
import
children
return
school
summer
spring
break
week
respiratori
virus
circul
associ
greater
asthma
symptom
frequent
loss
asthma
control
children
chronic
asthma
greater
symptom
respiratori
viral
infect
often
reduc
airway
function
fact
children
asthma
harbor
virus
lower
airway
even
wheez
howev
virus
tend
found
often
asthma
exacerb
asymptomat
mani
virus
associ
asthma
exacerb
includ
rsv
rv
influenza
lesser
extent
coronaviru
parainfluenza
adenoviru
metapneumoviru
howev
rv
common
viru
associ
childhood
asthma
exacerb
probabl
rv
preval
respiratori
virus
rv
caus
wide
spectrum
diseas
rang
asymptomat
sever
infect
requir
hospit
rv
infect
children
asthma
lead
exacerb
howev
sever
factor
predispos
children
exacerb
notabl
histori
atopi
studi
emerg
depart
found
detect
respiratori
viru
allergen
sensit
eosinophil
inflamm
risk
factor
acut
wheez
higher
level
aeroallergen
specif
ige
impart
greatest
risk
support
synergist
associ
rv
infect
ige
lead
increas
risk
wheez
similar
greater
associ
wheez
infect
infant
rva
rvc
infect
lead
sever
ill
often
associ
asthma
exacerb
rvb
furthermor
rvc
might
strongli
associ
sever
asthma
exacerb
asthma
hospit
stronger
inflammatori
respons
elicit
viru
viral
infect
increas
presenc
bacteri
colon
infect
airway
prospect
studi
found
rv
infect
increas
frequenc
quantiti
streptococcu
pneumonia
moraxella
catarrhali
haemophilu
influenza
detect
airway
secret
detect
bacteri
pathogen
associ
asthma
exacerb
children
asthma
symptomat
ill
children
without
asthma
role
bacteria
asthma
develop
exacerb
beyond
scope
review
clearli
potenti
interact
respiratori
virus
bacteri
biom
airway
could
also
drive
diseas
develop
andor
exacerb
understand
role
viral
infect
asthma
develop
basi
attempt
prevent
diseas
develop
reduc
sever
frequenc
asthma
exacerb
palivizumab
monoclon
antibodi
direct
rsv
thu
abl
reduc
rate
sever
rsv
infect
decreas
earli
episod
recurr
wheez
nonatop
children
atop
children
administ
highrisk
preterm
infant
differ
popul
consist
observ
rsv
appear
import
nonatop
asthma
despit
reduct
earli
wheez
reduct
rate
asthma
find
surpris
given
fact
rsv
risk
factor
wheez
infant
risk
recurr
wheez
diminish
age
anoth
rsv
antibodi
motavizumab
administ
highrisk
group
first
year
life
reduc
risk
hospit
admiss
wheez
lead
reduct
medic
treat
wheez
year
age
taken
togeth
studi
indic
monoclon
antibodi
therapi
direct
rsv
preterm
infant
reduc
bronchiol
recurr
wheez
whether
similar
result
would
seen
fullterm
infant
remain
demonstr
studi
found
oral
steroid
use
hospit
infant
first
wheez
decreas
risk
recurr
wheez
asthma
children
affect
rv
eczema
mechan
protect
known
like
mediat
decreas
inflammatori
respons
viral
infect
gener
rvinduc
wheez
respons
oral
steroid
wherea
rsvinduc
wheez
less
like
respond
oral
steroid
omalizumab
monoclon
antibodi
prevent
ige
bind
receptor
effect
use
treatment
moder
sever
asthma
reduc
number
asthma
exacerb
season
variat
exacerb
season
peak
asthma
exacerb
thought
mainli
attribut
viral
ill
reduct
exacerb
like
mean
antiig
effect
immun
respons
viral
infect
inde
treatment
omalizumab
either
yearround
season
pretreat
led
decreas
season
exacerb
decreas
rv
nasal
secret
especi
among
children
sever
asthma
mechan
effect
known
found
human
make
ige
rv
other
found
ige
made
rsv
find
suggest
antiig
might
block
asthma
exacerb
similar
manner
abl
inhibit
airway
allergeneinduc
asthma
altern
explan
base
observ
reduct
ige
led
increas
type
interferon
product
plasmacytoid
dendrit
cell
ex
vivo
find
suggest
antiig
might
increas
antivir
immun
consist
observ
treatment
omalizumab
decreas
sever
asthma
exacerb
associ
rv
side
note
random
clinic
trial
inhal
interferon
beta
type
interferon
found
benefit
treatment
primari
end
point
asthma
control
questionnair
score
forc
expiratori
volum
second
suggest
decreas
type
interferon
mechan
asthma
exacerb
argu
studi
adequ
power
demonstr
power
entir
studi
popul
particular
inclus
patient
mild
asthma
experienc
upper
respiratori
tract
infectioneinduc
exacerb
may
skew
result
toward
benefit
howev
benefit
seen
subpopul
sever
asthma
asthma
control
questionnair
score
peak
expiratori
flow
mention
one
potenti
mechanist
link
rv
infect
asthma
exacerb
could
product
type
interferon
patient
asthma
report
delay
decreas
antivir
respons
like
thought
attribut
decreas
product
innat
interferon
impair
type
interferon
express
like
contribut
asthma
allow
uncontrol
replic
viral
infect
leav
h
inflamm
uncheck
howev
assert
well
prove
fact
although
studi
support
idea
decreas
interferon
express
patient
asthma
other
disput
find
believ
howev
least
subgroup
patient
asthma
impair
type
interferon
respons
one
birth
cohort
studi
found
popul
patient
asthma
impair
ifn
respons
rv
year
age
also
increas
wheez
infanc
asthma
adolesc
frequent
asthma
exacerb
like
allerg
sensit
infanc
type
interferon
level
demonstr
invers
associ
chang
lung
function
eosinophilia
marker
inflamm
rv
infect
howev
mention
administr
type
interferon
signific
effect
improv
asthma
symptom
lung
function
patient
asthma
neutrophil
believ
play
import
role
interplay
viral
respiratori
infect
asthma
infant
hospit
rsv
virus
robust
neutrophil
influx
airway
epithelium
identifi
potenti
pathway
role
neutrophil
virusinduc
diseas
mous
model
use
sendai
viru
rodent
respiratori
viru
similar
rsv
found
viral
infect
mice
develop
postvir
atop
diseas
via
recruit
subset
neutrophil
express
product
cysteinyl
leukotrien
neutrophil
induc
express
highaffin
ige
receptor
lung
convent
dendrit
cell
time
mice
made
ige
sendai
viru
bound
express
convent
dendrit
cell
could
crosslink
viru
process
led
product
h
cell
chemoattract
drove
influx
h
cell
interleukin
il
product
subsequ
airway
hyperreact
mucou
cell
hyperplasia
human
found
evid
similar
pathway
neutrophil
found
peripher
blood
nasal
lavag
fluid
presenc
strongli
associ
allerg
diseas
symptom
respiratori
viral
infect
like
murin
counterpart
human
neutrophil
also
express
cysteinyl
leukotrien
receptor
receptor
cysteinyl
leukotrien
crosslink
ige
peripher
blood
human
convent
dendrit
cell
also
lead
product
final
other
found
respiratori
viral
infect
often
rv
total
serum
ige
level
increas
express
peripher
blood
convent
dendrit
cell
describ
previous
link
rv
infect
allerg
inflamm
develop
asthma
trigger
asthma
exacerb
studi
found
sensit
preced
viral
infect
allerg
inflamm
increas
airway
respons
rv
infect
suggest
lead
greater
viral
replic
describ
previous
rsv
infect
greater
associ
develop
nonatop
asthma
rv
infect
atop
asthma
howev
rsv
associ
develop
atopi
subset
patient
fact
viral
infect
includ
rsv
paramyxovir
infect
associ
develop
asthma
atopi
mous
model
found
exposur
nonvir
antigen
viral
infect
suffici
drive
specif
ige
product
nonvir
antigen
outlin
potenti
mechan
postvir
develop
atopi
furthermor
viral
infect
damag
barrier
function
airway
epithelium
allow
greater
absorpt
aeroallergen
lead
potenti
increas
allerg
sensit
healthi
airway
epithelium
rel
resist
rv
infect
howev
disrupt
airway
epithelium
present
allergen
sensit
present
may
promot
viral
replic
provid
access
deeper
cell
layer
report
favor
rv
replic
part
express
intercellular
adhes
molecul
receptor
one
receptor
rv
infect
cell
disrupt
airway
epithelium
promot
rv
replic
also
invit
absorpt
aeroallergen
infect
bacteri
pathogen
viral
infect
specif
rv
infect
associ
product
promot
type
airway
inflamm
remodel
primarili
drive
product
type
innat
lymphoid
cell
cell
capabl
produc
larg
amount
type
cytokin
drive
atop
respons
recent
public
also
found
dampen
innat
adapt
h
cytotox
respons
respons
viral
infect
may
anoth
factor
drive
virusinduc
asthma
exacerb
genet
compon
underli
possibl
drive
risk
asthma
develop
respiratori
viral
infect
still
explor
one
locu
associ
rvinduc
diseas
locat
presenc
polymorph
locu
influenc
risk
rvinduc
wheez
well
risk
rvwheez
infant
progress
develop
asthma
coast
copenhagen
prospect
studi
asthma
childhood
birth
cohort
anoth
polymorph
associ
risk
asthma
cadherinrel
famili
member
identifi
entri
factor
airway
epitheli
cell
rvc
although
like
genet
polymorph
may
predispos
infant
sever
rsv
infect
research
need
better
understand
one
potenti
genet
associ
link
lp
polymorph
h
immun
respons
favor
develop
asthma
rsv
infect
conclus
viral
infect
import
trigger
acut
wheez
episod
infanc
incept
exacerb
asthma
common
respiratori
virus
associ
develop
andor
exacerb
asthma
rsv
rv
seem
dispar
mechan
lead
diseas
rsv
appear
drive
asthma
infant
without
preexist
histori
atopi
wherea
rv
like
lead
asthma
children
alreadi
develop
allerg
phenotyp
understand
differ
mechan
import
begin
explor
potenti
primari
prevent
strategi
novel
therapeut
prevent
viralinduc
wheez
asthma
develop
atopi
